Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Insurance, Life”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,711 records · Page 95Linked to original sources
PubMed1991

Insurance forms.

Explore the source record for details and available documents.

Confidentiality↗
PubMed1991

[Disorders of lipid metabolism and insurance medicine practice].

The evaluation of lipometabolic disorders is presented within the framework of epidemiological and pathophysiological findings. Insurance medicine can base its risk assessment practices on the recommendations of American and European consensus conferences. The upper normal value for total cholesterol is in the vicinity of 200 mg/dl. The atherogenic risk of an elevated total cholesterol level can be further defined by determining the LDL and HDL cholesterol. The LDL cholesterol level should not exceed 160 mg/dl and the HDL level should not be lower than 35 mg/dl for men and 45 mg/dl for women. The quotients from the total/HDL cholesterol levels (normal value less than 6) and the LDL/HDL levels (normal value less than 4) can be used for differentiated risk assessment. Triglyceride levels exceeding 200 mg/dl are primarily to be taken into consideration as a risk indicator if there is a simultaneous reduction of HDL cholesterol. Additional parameters, such as nicotine abuse, hypertension, a family history of cardiovascular disease, impaired glucose tolerance, male sex, obesity and the existence of peripheral vascular disorders are also to be included in the risk profile. Determining additional lipometabolic substances is only of relevance to insurance medicine in individual cases.

Cause of Death↗
PubMed1990

[Hepatitis B and risk in insurance medicine].

Hepatitis B is one of the best-researched infectious diseases, both as regards the structure of the virus and in terms of diagnostic possibilities for identifying its stages, tracing its course and, perhaps most importantly, prognosing its development. Even though the range of test methods and supplementary analyses available is extensive and complex, it is nevertheless well worthwhile applying them selectively, as they allow the risk to be defined with relatively good accuracy. Of particular importance is the ability to distinguish between acute and chronic courses and, within the chronic course, between chronic persistent and chronic active hepatitis. Another major benefit is the possibility of predicting in good time malignant degeneration in the form of hepatocellular carcinoma. Though by contrast with South-East Asia and especially Central Africa, where the Hepatitis B morbidity rate can attain 80 to 90 per cent in some regions, the proportion of the population affected in Central Europe is relatively low (a figure of 5 per cent is quoted for West Germany), this disease is of particular significance because of its concentration among certain professional and risk groups and because a not inconsiderable proportion of policyholders are recruited from these groups.

Carcinoma, Hepatocellular↗
PubMed1991

[Alcohol and insurance in the Netherlands].

Ethyl-Alcohol is a very big problem in the world, but not a new addict. Drinking of more than 280 g. a week is disastrous for the most organs. The nervous system, the liver, the heart und circulatory system, even the bones and muscles will be damaged. With more than six-hundred-thousand victims in the Netherlands the alcohol addict is a great problem for the insurance business. Road accidents, health problems after several years, disability and early death, plays a role in the insurance policies.

Alcoholism↗
PubMed1991

[Late fatality after CO poisoning].

The report involves a 57-year-old man who was released from in-patient treatment relatively free of complaints 3 days after an attempted suicide with carbon monoxide. After a trouble-free interval, however, more and more organic brain symptoms accompanied by spasms appeared. In the end, the patient died 2 months later of an intermittent fulminating terminal embolism of the pulmonary artery with a thrombosis in the veins of the lower extremities. The clinical course and the anatomicopathological findings are discussed from the pathophysiological point of view. The question of a causal relationship between the "attempted suicide and lethal outcome" had to be answered in the affirmative as regards the insurance law aspects.

Brain↗